Hong Kong stocks are changing | China Resources Pharmaceutical Group (01093.HK) rose over 4% again. The treasury's quirky single-antibody injection III clinical trial has obtained topline analysis data.

According to the Securities Times app, Stone Pharmaceutical Group (01093.HK) has surged by over 4% again, with a gain of 4.37% as of the time of publication, reaching HK$8.36, and a trading volume of HK$5.79 billion.